Glutathione content but not gamma glutamyl cysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 1, 1997, Pages 75-80

  Newkirk, Kenneth ^b   Heffern, Joseph ^a   Sloman Moll, Erik ^b   Sessions, Roy B ^b   Rasmussen, Audrey A ^a   Andrews, Paul A ^c   Cullen, Kevin J ^a,d  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Glutamyl cysteine synthetase; Cisplatin; Glutathione; Head and neck cancer

Indexed keywords

BUTHIONINE SULFOXIMINE; CISPLATIN; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG RESISTANCE; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGRESSION ANALYSIS;

BUTHIONINE SULFOXIMINE; DRUG RESISTANCE; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HEAD AND NECK NEOPLASMS; HUMANS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030894152     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050629     Document Type: Article

References (31)

1. Wingo PA, Tong T, Bolden S (1995) Cancer statistics 1995. CA Cancer J Clin 45:8
2. Jacobs C, Lyman G, Velez-Garcia E, Sridhar KS, Knight W, Hochster H, Goodnough LT, Mortimer JE, Einhorn LH, Schacter L, Cherng N, Dalton T, Burroughs J, Rozeneweig M (1992) A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10:257
3. Wheeler RH (1990) Chemotherapy of patients with recurrent head and neck cancers. In: Jacobs C (ed) Carcinomas of the head and neck: evaluation, management. Kluwer Academic, Boston, pp 171 193
4. Kish JA, Weaver A, Jacobs J (1984) Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 53: 1819
5. Hong WK, Shapshay SM, Bhutani R, Craft ML, Ucmalkli A, Yamaguchi K, Vaughan CW, Strong MS (1979) Induction chemotherapy in advanced squamous head and neck carcinoma with high dose cisplatin and bleomycin infusion. Cancer 44:19
6. The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685
7. Jacobs C, Goffinet DR, Goffinet L, Kohler M, Fee WE (1987) Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer: a report from the Northern California Oncology Group. Cancer 60(6): 1178
8. Hong WK, Lippman SM, Wolf GT (1993) Recent advances in head and neck cancer larynx preservation and cancer chemo-prevention: the Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 53(21):5113
9. Andrews PA (1994) Mechanisms of acquired resistance to cisplatin. Cancer Treat Res 73:217
10. Meister A (1988) On the discovery of glutathione. Trends Biochem Sci 13(5):185
11. Mistry P, Harrap KR (1991) Historical aspects of glutathione and cancer chemotherapy. Pharmacol Ther 49:125
12. Meister A (1994) Glutathione, ascorbate, and cellular protection. Cancer Res 54 [Suppl 7]:1969s
13. Hamilton TC, Winker MA, Louie KG, Batist G, Behrens BC, Tsuruo T, Grotzinger KR, McKoy WM, Young RC, Ozols RF, (1985) Augmentation of adriamycin. melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem Pharmacol 34(14):2583
14. Meister A (1992) Depletion of glutathione in normal and malignant human cells. J Natl Cancer Inst 84:1601
15. Tew KD (1994) Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54:4313
16. Ozols RF, O'Dwyer PJ, Hamilton TC, Young RC (1990) The role of glutathione in drug resistance. Cancer Treat Rev 17A:45
17. Russo A, DeGraff W, Friedman N, Mitchell JB (1986) Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res 46:2845
18. Hosking LK, Whelan RDH, Shellard SA, Bedford P, Hill BT (1990) An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumor agents shown by a range of tumor cell lines. Biochem Pharmacol 40:1833
19. Moore WR, Anderson ME, Meister A, Murata K, Kimura A (1989) Increased capacity for glutathione synthesis enhances resistance to radiation in Escherichia coli: a possible model for mammalian cell protection. Proc Natl Acad Sci USA 86:1461
20. Mistry P, Kelland LR, Abel G, Sidhar S, Harrap KR (1991) The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Br J Cancer 64:215
21. Yellin SA, Davidson BJ, Pinto JT, Sacks PG, Qiao C, Schantz SP (1994) Relationship of glutathione and glutathione S-transferase to cisplatin sensitivity in human head and neck squamous carcinoma cell lines. Cancer Lett 85:223
22. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME (1992) High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89(7):3070
23. Carey TE (1994) Head and neck tumor cell lines. In: Hay RJ, Park J-G, Gazdar A (eds) Atlas of human tumor cell lines. Academic Press, San Diego, pp 79 120
24. Teicher BA, Holden SA, Kelley MJ, Shea TC, Cucchi CA, Rosowsky A, Henner WD, Frei E (1987) Characterization of a human squamous carcinoma cell line resistant to cis-diammine dichloroplatinum. Cancer Res 47:388
25. Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 27:502
26. Chirgwin JM, Przybla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18:5294
27. Pendyala I, Creaven PJ, Perez R, Zdanowicz JR, Raghavan D (1995) Intracellular glutathione and cytotoxicity of platinum complexes. Cancer Chemother Pharmacol 36:271
28. Yao K, Godwin AK, Johnson SW, Ozols RF, O'Dwyer PJ, Hamilton TC (1995) Evidence for altered regulation of γ-glutamyl cysteine synthetase gene expression among cisplatin-sensitive and cisplatin resistant human ovarian cancer cell lines. Cancer Res 55: 4367
29. El-akawi Z, Zandowicz J, Creaven PJ, Abu-hadid M, Perez R, Penyala L (1996) Induction of γ-glutamyl transpeptidase (γGT) mRNA by platinum complexes. Proc Annu Meet Amer Assoc Cancer Res 37:A2755
30. Gallo JM, Brennan J, Hamilton TC, Halbherr T, Laub PB, Ozols RF, O'Dwyer PJ (1995) Time-dependent pharmacodynamic models in cancer chemotherapy: population pharmacodynamic model for glutathione depletion following modulation by buthionine sulfoximine in a phase I clinical trial of melphalan and BSO. Cancer Res 55:4507
31. Chow S, Hedley D (1995) Flow cytometric determination of glutathione in clinical samples. Cytometry 21:68